Immune Cell Therapy for Advanced Solid Tumors

Clinical trial NCT07260058 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07260058
Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer (Locally Advanced or Metastatic)Liver Cancer (Locally Advanced or Metastatic)Colorectal Cancer (Locally Advanced or Metastatic)Breast Cancer (Locally Advanced or Metastatic)Advanced Solid Tumors

Start date: 2025-12-01
Primary completion: 2027-06-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.